Cancer Resistance Revealed
Through the Single Cell Intracellular Proteome, Masked Through Bulk and Genomics
![[wpbb post:title]](https://isoplexis.com/wp-content/uploads/2020/04/Webinar-Website-Covers-4.30_Artboard-2.png)
Rui Zheng, PhD, VP of Innovations, IsoPlexis
Learn how functional proteomics is filling the translational gap in single-cell technology
See how IsoPlexis' single-cell proteomic data is predicting resistance in tumor cells
Discover how single-cell phosphoproteomics informs targeted combination therapies
